Related Experiment Video
Updated: Jun 16, 2026

12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Follicular dendritic cell sarcoma of tonsil
Zahid Suhail1, Mohammad Ayub Musani, Salman Afaq
1Department of ENT, Karachi Medical and Dental College and Abbasi Shaheed Hospital, Karachi. drzahidsuhail7@hotmail.com
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|February 10, 2010
Summary
Follicular dendritic cell sarcoma (FDCS) is a rare tonsil neoplasm. This case highlights the importance of considering FDCS in adult tonsil masses and using specific markers for diagnosis.
Area of Science:
- Oncology
- Pathology
Background:
- Follicular dendritic cell sarcoma (FDCS) is an exceptionally rare tumor with limited reported cases worldwide, particularly involving the tonsil.
- The diagnosis of FDCS can be challenging due to its rarity and potential for mimicry of other lymphoid or epithelial lesions.
Observation:
- A case of FDCS in the tonsil of a 52-year-old woman is presented, initially presenting as unilateral tonsillar enlargement.
- Diagnostic tonsillectomy was performed, with subsequent histological review and immunohistochemical staining confirming the diagnosis of FDCS.
- The patient had no evidence of neck node involvement, and bone scan revealed no metastasis.
Findings:
- Histopathological and immunohistochemical analysis confirmed the diagnosis of follicular dendritic cell sarcoma.
- Postoperative chemotherapy was administered, and the patient showed no evidence of local or regional recurrence after one year of follow-up.
- Bone scan excluded metastatic disease.
Implications:
- Follicular dendritic cell sarcoma should be included in the differential diagnosis for any adult tonsillar mass.
- Immunohistochemical markers such as S100, CD21, and CD35 are crucial for accurate diagnosis of FDCS.
- Early diagnosis and appropriate management, including chemotherapy, may lead to favorable outcomes in FDCS.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...